| 11260053 |
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
Bronislava Gedulin, Andrew A. Young |
2022-03-01 |
| 10555950 |
Bile acid recycling inhibitors for treatment of obesity and diabetes |
Andrew A. Young, Bronislava Gedulin |
2020-02-11 |
| 10251880 |
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
Bronislava Gedulin, Andrew A. Young |
2019-04-09 |
| 10188646 |
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
Bronislava Gedulin, Andrew A. Young |
2019-01-29 |
| 10028952 |
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof |
Andrew A. Young, Bronislava Gedulin |
2018-07-24 |
| 9656017 |
Infusion delivery devices and methods |
— |
2017-05-23 |
| 9345715 |
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof |
Andrew A. Young, Bronislava Gedulin |
2016-05-24 |
| 9339480 |
Bile acid recycling inhibitors for treatment of obesity and diabetes |
Andrew A. Young, Bronislava Gedulin |
2016-05-17 |
| 8318663 |
Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent |
Andrew A. Young, Bronislava Gedulin |
2012-11-27 |
| 5942227 |
Pharmaceutical compositions containing antibodies to amylin |
Garth J. S. Cooper |
1999-08-24 |
| 5716619 |
Treatment of type 2 diabetes mellitus |
Garth J. S. Cooper |
1998-02-10 |
| 5281581 |
Treatment of insulin resistance |
Garth J. S. Cooper |
1994-01-25 |
| 5266561 |
Treatment of type 2 diabetes mellitus |
Garth J. S. Cooper |
1993-11-30 |
| 4486530 |
Immunometric assays using monoclonal antibodies |
Gary S. David |
1984-12-04 |
| 4376110 |
Immunometric assays using monoclonal antibodies |
Gary S. David |
1983-03-08 |